HSBC reiterated their hold rating on shares of UnitedHealth Group (NYSE:UNH – Free Report) in a research note published on Tuesday morning, Marketbeat.com reports. HSBC currently has a $490.00 target price on the healthcare conglomerate’s stock.
Several other research firms have also weighed in on UNH. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Erste Group Bank raised shares of UnitedHealth Group to a “strong-buy” rating in a research note on Wednesday, April 16th. Truist Financial cut their target price on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating on the stock in a report on Monday. Argus downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday. Finally, Barclays lowered their price target on UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating for the company in a report on Monday. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and four have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $608.00.
Read Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Price Performance
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the firm earned $6.91 earnings per share. As a group, research analysts anticipate that UnitedHealth Group will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.97%. UnitedHealth Group’s payout ratio is 35.18%.
Hedge Funds Weigh In On UnitedHealth Group
A number of institutional investors have recently bought and sold shares of UNH. NewSquare Capital LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group in the fourth quarter valued at about $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at about $28,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $30,000. Finally, Aster Capital Management DIFC Ltd acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- Expert Stock Trading Psychology Tips
- How to Invest in Micro-Cap Stocks Like a Pro
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Investors Sell Microsoft Stock on OpenAI News—Time to Buy?
- 3 Warren Buffett Stocks to Buy Now
- Take-Two Interactive: A Defensive Play Set to Explode
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.